Abstract
Epidermal growth factor (EGF) receptor expression in 31 primary human bladder tumours was quantitated using both structural and functional assays and the EGF receptor gene in the same tumours was analyzed by Southern blot analysis. Immunocytochemical studies using the EGFR1 monoclonal antibody (Mab) showed a significant correlation between EGF receptor levels and the stage and grade of the tumours. Autophosphorylation assays employed to evaluate the receptor's tyrosine kinase activity gave results which in general were consistent with the immunocytochemical data. Using internally controlled immunocytochemical studies with two Mabs and Southern blot analysis of DNA isolated from the tumours, no evidence was obtained for the production of truncated receptors similar to those encoded by the v-erb-B oncogene. Gene amplification was not found in any of the superficial tumours, but one invasive tumour with high EGF receptor expression had an 8-10 fold amplification of the EGF receptor gene. The EGF receptor isolated from this tumour showed a normal pattern of tyrosine phosphorylation at all three major autophosphorylation sites. Our detailed study is consistent with the correlation previously found between EGF receptor expression and stage and grade of bladder tumours, and suggests that at this level of analysis EGF receptors in bladder tumours are not abnormal in structure or size, autophosphorylation activity, or gene structure.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Berger, M., Greenfield, C., Gullick, W. et al. Evaluation of epidermal growth factor receptors in bladder tumours. Br J Cancer 56, 533–537 (1987). https://doi.org/10.1038/bjc.1987.238
Issue Date:
DOI: https://doi.org/10.1038/bjc.1987.238
This article is cited by
-
Role of tyrosine kinases in bladder cancer progression: an overview
Cell Communication and Signaling (2020)
-
Recent Advances in Treatment of Advanced Urothelial Carcinoma
Current Urology Reports (2012)
-
Epidermal growth factor receptor structural alterations in gastric cancer
BMC Cancer (2008)
-
Isolation and characterization of a novel bladder cancer cell line: Inhibition by epidermal growth factor
In Vitro Cellular & Developmental Biology - Animal (1998)